Shaoming Zhu

1.3k total citations · 1 hit paper
24 papers, 911 citations indexed

About

Shaoming Zhu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shaoming Zhu has authored 24 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shaoming Zhu's work include Bladder and Urothelial Cancer Treatments (6 papers), Ferroptosis and cancer prognosis (4 papers) and Sperm and Testicular Function (4 papers). Shaoming Zhu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Ferroptosis and cancer prognosis (4 papers) and Sperm and Testicular Function (4 papers). Shaoming Zhu collaborates with scholars based in China, United States and Australia. Shaoming Zhu's co-authors include Chong-xian Pan, Wenru Song, Lei Zheng, Hongtao Liu, Tian Zhang, Zihai Li, Delong Liu, Cheng Fan, Weimin Yu and Xiao Yang and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Functional Materials and Clinical Cancer Research.

In The Last Decade

Shaoming Zhu

24 papers receiving 902 citations

Hit Papers

Combination strategies to maximize the benefits of cancer... 2021 2026 2022 2024 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoming Zhu China 14 344 329 232 181 150 24 911
Abhijit Aithal United States 12 428 1.2× 372 1.1× 218 0.9× 94 0.5× 77 0.5× 23 809
Iñigo Martínez-Zubiaurre Norway 20 371 1.1× 579 1.8× 291 1.3× 152 0.8× 98 0.7× 33 1.1k
Daniel Guimarães Tiezzi Brazil 17 267 0.8× 488 1.5× 281 1.2× 117 0.6× 61 0.4× 77 1.1k
Mariana Scaranti Brazil 9 269 0.8× 323 1.0× 73 0.3× 111 0.6× 123 0.8× 25 832
Julianne D. Twomey United States 10 302 0.9× 504 1.5× 256 1.1× 101 0.6× 90 0.6× 18 988
Renquan Lu China 21 625 1.8× 405 1.2× 121 0.5× 196 1.1× 80 0.5× 62 1.2k
Moo Jun Baek South Korea 20 532 1.5× 492 1.5× 174 0.8× 196 1.1× 74 0.5× 87 1.3k
Bo Zhu China 19 398 1.2× 522 1.6× 423 1.8× 197 1.1× 167 1.1× 50 1.1k

Countries citing papers authored by Shaoming Zhu

Since Specialization
Citations

This map shows the geographic impact of Shaoming Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoming Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoming Zhu more than expected).

Fields of papers citing papers by Shaoming Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoming Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoming Zhu. The network helps show where Shaoming Zhu may publish in the future.

Co-authorship network of co-authors of Shaoming Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoming Zhu. A scholar is included among the top collaborators of Shaoming Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoming Zhu. Shaoming Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farrukh, Hizra, Zheng Zhu, Shaoming Zhu, et al.. (2023). A phase II trial with copanlisib plus avelumab as maintenance therapy for metastatic bladder cancer after platinum-based chemotherapy.. Journal of Clinical Oncology. 41(16_suppl). TPS4610–TPS4610. 2 indexed citations
2.
Zhu, Zheng, Ai‐Hong Ma, Hongyong Zhang, et al.. (2022). Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer. Clinical Cancer Research. 28(21). 4820–4831. 19 indexed citations
3.
Chen, Kang, Shaoming Zhu, Weimin Yu, et al.. (2022). Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer. Frontiers in Oncology. 12. 774307–774307. 6 indexed citations
4.
Ji, Xing, Chen Wu, Kang Chen, et al.. (2022). TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers. 14(19). 4809–4809. 17 indexed citations
5.
Zhu, Shaoming, Zheng Zhu, Ai-Hong Ma, et al.. (2021). Preclinical Models for Bladder Cancer Research. Hematology/Oncology Clinics of North America. 35(3). 613–632. 20 indexed citations
6.
Yu, Xi, Shenglan Li, Yang Du, et al.. (2021). TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway. Frontiers in Oncology. 10. 613869–613869. 27 indexed citations
7.
Zhu, Shaoming, Tian Zhang, Lei Zheng, et al.. (2021). Combination strategies to maximize the benefits of cancer immunotherapy. Journal of Hematology & Oncology. 14(1). 156–156. 442 indexed citations breakdown →
8.
Wu, Chen, Sheng Zhao, Weimin Yu, et al.. (2021). SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β‐catenin pathway. Journal of Cellular and Molecular Medicine. 25(22). 10684–10697. 9 indexed citations
9.
Lin, Kai, Zhao Ma, Jin Li, et al.. (2020). Single Small Molecule‐Assembled Mitochondria Targeting Nanofibers for Enhanced Photodynamic Cancer Therapy In Vivo. Advanced Functional Materials. 31(10). 58 indexed citations
10.
Zhu, Shaoming, et al.. (2020). Traditional Classification and Novel Subtyping Systems for Bladder Cancer. Frontiers in Oncology. 10. 102–102. 72 indexed citations
11.
Zhu, Shaoming, Cheng Fan, Xiangjun Zhou, et al.. (2020). [Effect of testicular autophagy on spermatogenic cells in varicocele rats].. PubMed. 26(2). 111–117. 3 indexed citations
12.
Qu, Zhenzhen, Lili Zhang, Shaoming Zhu, et al.. (2019). Overexpression of the transcription factor HAC1 improves nerolidol production in engineered yeast. Enzyme and Microbial Technology. 134. 109485–109485. 21 indexed citations
13.
Yang, Xiao, Shaoming Zhu, Li Li, et al.. (2018). Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis. OncoTargets and Therapy. Volume 11. 1457–1474. 63 indexed citations
14.
Zhu, Shaoming, et al.. (2017). Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis. Medicine. 96(4). e5988–e5988. 14 indexed citations
15.
Ning, Jinzhuo, Ting Rao, Cheng Fan, et al.. (2017). Effect of varicocelectomy treatment on spermatogenesis and apoptosis via the induction of heat shock protein 70 in varicocele-induced rats. Molecular Medicine Reports. 16(4). 5406–5412. 18 indexed citations
16.
Zhu, Shaoming, Ting Rao, Xiao Yang, et al.. (2017). Autophagy may play an important role in varicocele. Molecular Medicine Reports. 16(4). 5471–5479. 26 indexed citations
17.
Zhu, Shaoming, et al.. (2016). Lymphocyte–monocyte ratio at admission predicts possible outcomes in patients with acute-on-chronic liver failure. European Journal of Gastroenterology & Hepatology. 29(1). 31–35. 11 indexed citations
18.
Zhu, Ming, Jianming Guan, Jianghua Chen, et al.. (2012). Dialysis Methods May Affect Carotid Intima–Media Thickness in Chinese End-Stage Renal Disease Patients. Renal Failure. 34(10). 1206–1211. 4 indexed citations
19.
Zhu, Shaoming, et al.. (2012). Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment. Hepatobiliary & pancreatic diseases international. 11(2). 172–176. 9 indexed citations
20.
Zhu, Shaoming, et al.. (2011). Protein structural classification and family identification by multifractal analysis and wavelet spectrum. Chinese Physics B. 20(1). 10505–10505. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026